Chronic Kidney Disease (Stages 4 and 5)
13
3
4
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
15%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (13)
CANagliflozin In DIALysis Patients
Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited Potassium Content in Patients With Chronic Kidney Disease: A Pilot Study
Symptom Monitoring With Supported Feedback in Advanced Chronic Kidney Disease
The Practicality and Utility of Measured vs Estimated GFR in adCKD
Prospective AnalysiS of Self medIcation With phytOtherapy in Nephropatic Patients.
Intradialytic Rehabilitation and Functional Independence in Hemodialysis Patients
Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage
Respiratory Biofeedback Added to Strengthening Training in Patients With Chronic Kidney Disease
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases
Outcome of Use of a Novel Modulator of Oxidative Phosphorylation on Kidney Function in Patients With Progressive Chronic Kidney Disease
Physical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions
Assessment of Protein Intake Using 2 Types of Nutritional Collection in Chronic Kidney Disease.